SOPHIA ANTIPOLIS – The European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC), is set to host EHRA 2023, a landmark scientific congress celebrating two decades of progress in arrhythmia management. Taking place from April 16 to 18 in Barcelona, Spain, and virtually, the congress will convene experts from across the globe to explore cutting-edge research and innovations in heart rhythm disorders, according to a press release published on EuropaWire.

EHRA 2023 promises an engaging scientific program, featuring over 120 sessions covering a diverse array of topics, from the latest advancements in digital health to emerging treatments such as pulsed field ablation. Notable sessions will delve into the use of artificial intelligence for atrial fibrillation detection and treatment, strategies for sudden death prevention, and gender disparities in device therapy. Professor Andrea Sarkozy and Professor Serge Boveda, EHRA Scientific Programme Co-Chairpersons, underscored the congress’s commitment to addressing key challenges and driving innovation in arrhythmia management.

Digital health will take center stage at EHRA 2023, with discussions on the role of wearable devices, remote monitoring, and AI-driven technologies in improving patient care. Professor Sarkozy emphasized the transformative potential of digital innovations, highlighting their role in empowering patients and advancing personalized care.

Gender disparities in arrhythmia management will also be a focal point, with experts exploring tailored approaches to address the unique needs of women. Professor Sarkozy emphasized the importance of gender-specific research and treatment strategies, advocating for more inclusive clinical trials and improved access to invasive procedures for women.

AI’s role in revolutionizing arrhythmia diagnosis and treatment will be a key theme, with sessions focusing on its potential to enhance risk stratification and guide therapeutic interventions. Professor Boveda highlighted AI’s promise in identifying novel ablation targets and predicting sudden cardiac death, underscoring its transformative impact on arrhythmia management.

Sustainability and innovation will be recurring themes throughout the congress, with sessions examining the environmental and economic implications of catheter reuse and exploring novel treatment modalities such as pulsed field ablation. Professor Boveda emphasized the importance of environmental responsibility in electrophysiology, calling for collaborative efforts to address pressing challenges.

EHRA 2023 represents a pivotal moment in the field of arrhythmia management, uniting clinicians, scientists, and industry leaders in a shared mission to advance patient care and drive innovation. Attendees can anticipate dynamic discussions, groundbreaking research presentations, and unparalleled networking opportunities at this premier arrhythmias meeting in Europe.